Curis Lifesciences Ltd

Curis Lifesciences Annual General Meeting

Curis Lifesciences filed its 10th AGM notice and FY 2025-26 Annual Report. The meeting is scheduled for September 29, 2026.

Curis Lifesciences Board Meeting Outcome

Curis Lifesciences Limited approved the Director's Report, related party transactions, and scheduled its 10th Annual General Meeting for September 29, 2026. Board outcomes were finalized.

Curis Lifesciences Management Change

Curis Lifesciences Limited announced the resignation of Mr. Nikhil Purohit as Company Secretary and Compliance Officer, effective September 3, 2026.

Curis Lifesciences Other Announcement

Curis Lifesciences Limited submitted the RTA confirmation certificate for the quarter ended June 30, 2026, as required under SEBI Regulation 74(5).

Curis Lifesciences Merger & Restructuring Worth ₹0.05 Cr

Curis Lifesciences Limited has acquired a 49.95% stake in CUROSUN PHARMACEUTICAL NIG LTD, Nigeria, for Rs. 5 Lakhs to expand its pharmaceutical market presence.

Value

₹0.05 Cr

Curis Lifesciences Legal & Regulatory

Curis Lifesciences paid a Rs. 5,900 fine to NSE for delayed RPT disclosure compliance. The Board attributed the delay to technical portal errors.

Curis Lifesciences Management Change

Curis Lifesciences appointed Mr. Devabhai Hamirbhai Jadeja as an Independent Director for five years. He brings extensive experience in financial management and accounting to the board.

Execution

5 years

Curis Lifesciences Results Correction

Curis Lifesciences Limited submitted clarifications and corrected financial results for FY2026 following NSE queries. The update rectifies XBRL discrepancies and integrates issue proceed utilization disclosures.